Circulating interleukin-4 is associated with a systemic T cell response against tumor-associated antigens in treatment-naïve patients with resectable non-small-cell lung cancer
Spontaneous T cell responses to tumor-associated antigens (TAs) in the peripheral blood of patients with non-small-cell lung cancer (NSCLC) may be relevant for postoperative survival. However, the conditions underlying these T cell responses remain unclear. We quantified the levels of 27 cytokines i...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
24 November 2020
|
| In: |
Cancers
Year: 2020, Jahrgang: 12, Heft: 12, Pages: 1-20 |
| ISSN: | 2072-6694 |
| DOI: | 10.3390/cancers12123496 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/cancers12123496 Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2072-6694/12/12/3496 
|
| Verfasserangaben: | Seyer Safi, Yoshikane Yamauchi, Hans Hoffmann, Wilko Weichert, Philipp J. Jost, Hauke Winter, Thomas Muley and Philipp Beckhove |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1788647459 | ||
| 003 | DE-627 | ||
| 005 | 20220820123012.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220207s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/cancers12123496 |2 doi | |
| 035 | |a (DE-627)1788647459 | ||
| 035 | |a (DE-599)KXP1788647459 | ||
| 035 | |a (OCoLC)1341441433 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Safi, Seyer |d 1980- |e VerfasserIn |0 (DE-588)136460437 |0 (DE-627)694401749 |0 (DE-576)301032416 |4 aut | |
| 245 | 1 | 0 | |a Circulating interleukin-4 is associated with a systemic T cell response against tumor-associated antigens in treatment-naïve patients with resectable non-small-cell lung cancer |c Seyer Safi, Yoshikane Yamauchi, Hans Hoffmann, Wilko Weichert, Philipp J. Jost, Hauke Winter, Thomas Muley and Philipp Beckhove |
| 246 | 3 | 0 | |a four |
| 264 | 1 | |c 24 November 2020 | |
| 300 | |a 20 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 03.03.2022 | ||
| 520 | |a Spontaneous T cell responses to tumor-associated antigens (TAs) in the peripheral blood of patients with non-small-cell lung cancer (NSCLC) may be relevant for postoperative survival. However, the conditions underlying these T cell responses remain unclear. We quantified the levels of 27 cytokines in the peripheral blood and tumor tissues from treatment-naïve patients with NSCLC (n = 36) and analyzed associations between local and systemic cytokine profiles and both TA-specific T cell responses and clinical parameters. We defined T cell responders as patients with circulating T cells that were reactive to TAs and T cell nonresponders as patients without detectable TA-specific T cells. TA-specific T cell responses were correlated with serum cytokine levels, particularly the levels of interleukin(IL)-4 and granulocyte colony-stimulating factor (G-CSF), but poorly correlated with the cytokine levels in tumor tissues. Nonresponders showed significantly higher serum IL-4 levels than responders (p = 0.03); the predicted probability of being a responder was higher for individuals with low serum IL-4 levels. In multivariable Cox regression analyses, in addition to IL-4 (hazard ratio (HR) 2.8 (95% confidence interval (CI): 0.78-9.9); p = 0.116), the age-adjusted IL-8 level (HR 3.9 (95% CI: 1.05-14.5); p = 0.042) predicted tumor recurrence. However, this study included data for many cytokines without adjustment for multiple testing; thus, the observed differences in IL-4 or IL-8 levels might be incidental findings. Therefore, additional studies are necessary to confirm these results. | ||
| 650 | 4 | |a cytokine | |
| 650 | 4 | |a immunotherapy | |
| 650 | 4 | |a lung cancer | |
| 650 | 4 | |a T cells | |
| 700 | 1 | |a Yamauchi, Yoshikane |e VerfasserIn |0 (DE-588)1155426819 |0 (DE-627)1017717273 |0 (DE-576)50163844X |4 aut | |
| 700 | 1 | |a Hoffmann, Hans |d 1957- |e VerfasserIn |0 (DE-588)1022900455 |0 (DE-627)71732852X |0 (DE-576)366147730 |4 aut | |
| 700 | 1 | |a Weichert, Wilko |d 1970-2023 |e VerfasserIn |0 (DE-588)123509106 |0 (DE-627)56134650X |0 (DE-576)293740461 |4 aut | |
| 700 | 1 | |a Jost, Philipp J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Winter, Hauke |e VerfasserIn |0 (DE-588)1162076038 |0 (DE-627)1025509773 |0 (DE-576)176791531 |4 aut | |
| 700 | 1 | |a Muley, Thomas |e VerfasserIn |0 (DE-588)1056885432 |0 (DE-627)794179169 |0 (DE-576)16759284X |4 aut | |
| 700 | 1 | |a Beckhove, Philipp |d 1969- |e VerfasserIn |0 (DE-588)121272842 |0 (DE-627)705350169 |0 (DE-576)292620748 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancers |d Basel : MDPI, 2009 |g 12(2020), 12, Artikel-ID 3496, Seite 1-20 |h Online-Ressource |w (DE-627)614095670 |w (DE-600)2527080-1 |w (DE-576)313958548 |x 2072-6694 |7 nnas |a Circulating interleukin-4 is associated with a systemic T cell response against tumor-associated antigens in treatment-naïve patients with resectable non-small-cell lung cancer |
| 773 | 1 | 8 | |g volume:12 |g year:2020 |g number:12 |g elocationid:3496 |g pages:1-20 |g extent:20 |a Circulating interleukin-4 is associated with a systemic T cell response against tumor-associated antigens in treatment-naïve patients with resectable non-small-cell lung cancer |
| 856 | 4 | 0 | |u https://doi.org/10.3390/cancers12123496 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.mdpi.com/2072-6694/12/12/3496 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220207 | ||
| 993 | |a Article | ||
| 994 | |a 2020 | ||
| 998 | |g 121272842 |a Beckhove, Philipp |m 121272842:Beckhove, Philipp |d 50000 |e 50000PB121272842 |k 0/50000/ |p 8 |y j | ||
| 998 | |g 1056885432 |a Muley, Thomas |m 1056885432:Muley, Thomas |d 910000 |d 950000 |d 950900 |e 910000PM1056885432 |e 950000PM1056885432 |e 950900PM1056885432 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |p 7 | ||
| 998 | |g 1162076038 |a Winter, Hauke |m 1162076038:Winter, Hauke |d 910000 |d 950000 |d 950900 |d 50000 |e 910000PW1162076038 |e 950000PW1162076038 |e 950900PW1162076038 |e 50000PW1162076038 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |k 0/50000/ |p 6 | ||
| 998 | |g 1022900455 |a Hoffmann, Hans |m 1022900455:Hoffmann, Hans |d 910000 |d 950000 |d 950900 |d 50000 |e 910000PH1022900455 |e 950000PH1022900455 |e 950900PH1022900455 |e 50000PH1022900455 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |k 0/50000/ |p 3 | ||
| 998 | |g 136460437 |a Safi, Seyer |m 136460437:Safi, Seyer |d 50000 |e 50000PS136460437 |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1788647459 |e 405171652X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"name":{"displayForm":["Seyer Safi, Yoshikane Yamauchi, Hans Hoffmann, Wilko Weichert, Philipp J. Jost, Hauke Winter, Thomas Muley and Philipp Beckhove"]},"person":[{"given":"Seyer","display":"Safi, Seyer","family":"Safi","role":"aut"},{"display":"Yamauchi, Yoshikane","given":"Yoshikane","role":"aut","family":"Yamauchi"},{"role":"aut","family":"Hoffmann","display":"Hoffmann, Hans","given":"Hans"},{"given":"Wilko","display":"Weichert, Wilko","family":"Weichert","role":"aut"},{"family":"Jost","role":"aut","display":"Jost, Philipp J.","given":"Philipp J."},{"family":"Winter","role":"aut","given":"Hauke","display":"Winter, Hauke"},{"display":"Muley, Thomas","given":"Thomas","role":"aut","family":"Muley"},{"family":"Beckhove","role":"aut","given":"Philipp","display":"Beckhove, Philipp"}],"recId":"1788647459","note":["Gesehen am 03.03.2022"],"title":[{"title":"Circulating interleukin-4 is associated with a systemic T cell response against tumor-associated antigens in treatment-naïve patients with resectable non-small-cell lung cancer","title_sort":"Circulating interleukin-4 is associated with a systemic T cell response against tumor-associated antigens in treatment-naïve patients with resectable non-small-cell lung cancer"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"doi":["10.3390/cancers12123496"],"eki":["1788647459"]},"physDesc":[{"extent":"20 S."}],"relHost":[{"name":{"displayForm":["Molecular Diversity Preservation International (MDPI)"]},"recId":"614095670","title":[{"title":"Cancers","title_sort":"Cancers"}],"id":{"eki":["614095670"],"issn":["2072-6694"],"zdb":["2527080-1"]},"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedKey":"2009","publisherPlace":"Basel","publisher":"MDPI","dateIssuedDisp":"2009-"}],"language":["eng"],"part":{"issue":"12","extent":"20","pages":"1-20","text":"12(2020), 12, Artikel-ID 3496, Seite 1-20","year":"2020","volume":"12"},"pubHistory":["1.2009 -"],"note":["Gesehen am 27.05.2020"],"disp":"Circulating interleukin-4 is associated with a systemic T cell response against tumor-associated antigens in treatment-naïve patients with resectable non-small-cell lung cancerCancers","type":{"bibl":"periodical","media":"Online-Ressource"}}],"origin":[{"dateIssuedDisp":"24 November 2020","dateIssuedKey":"2020"}]} | ||
| SRT | |a SAFISEYERYCIRCULATIN2420 | ||